Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of adverse events, a new trial shows.

This transcript has been edited for clarity. John Kane, MD: I am Dr John Kane. I am a professor of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New ...

For decades, prevailing wisdom held that to overcome addiction, the most important thing to do was to flush or “clean” the drugs out of one’s system, to get a fresh start. But more and more, research ...

Prostate cancer relapse treatment could be cut from 35 visits to just five. See how new radiation technology may change your ...

We conducted a search using MEDLINE/PubMed, the Cochrane library and PsycINFO (last search date January 2011) for randomized, controlled trials of relapse prevention or maintenance treatment of ...

Relapse, or recurrence, occurs when multiple myeloma symptoms return, such as bone pain, fatigue, and kidney problems. It’s possible to live for many years after a relapse of multiple myeloma. Outlook ...

Explore how experts personalize second-line myeloma care at first relapse, weighing CAR T, bispecifics, and evolving sequencing amid rapid approvals. In this episode, 'First Relapse in Multiple ...

Multiple sclerosis (MS) is a condition that disrupts the information pathways that connect your brain and your body. From time to time, the symptoms of MS can unexpectedly worsen. When symptoms ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this author to personalize your feed and get ...

Recovery from an eating disorder is typically a long process. Many people may even relapse during this time. Relapse is often due to stressful situations. Anorexia nervosa describes an eating disorder ...